ThriftyMan
Posted - 14 hours ago
$DMAC Is that volume for real? That is wild.
Sukitt
Posted - 15 hours ago
$DMAC 1 million+ volume out the gate. Strange. Probably nothing.
d_risk
Posted - 1 week ago
$DMAC - DiaMedica Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors New risk factors: DM199 program expansion into PE faces timing, regulatory, cost, and enrollment risks; regulatory approval in South Africa; potential financial impact from adverse trial data. #Risk @Dismedica https://d-risk.ai/DMAC/10-Q/2024-11-13
justiceforb_85
Posted - 1 week ago
$DMAC do we have any data for efficacy of rinvecalinase in either stroke or pre-eclampsia?
swingingtech
Posted - 1 month ago
$IAG $DMAC $HIVE
https://wallstreetwaves.com/best-momentum-stocks-to-buy-for-october-14th/
briefingcom
Posted - 1 month ago
$DMAC: DiaMedica Therapeutics announces regulatory approval has been received to initiate a Phase 2 clinical trial with DM199, its proprietary recombinant serine protease, for the treatment of preeclampsia https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241009082819DMAC&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
Doozio
Posted - 1 month ago
$DMAC da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️
kshonstocks
Posted - 1 month ago
$DMAC hitting scan, like pattern
IN0V8
Posted - 1 month ago
$DMAC Opportunity H.C. Wainwright initiates coverage with buy rating
Sukitt
Posted - 1 month ago
$DMAC
eneub87
Posted - 1 month ago
$DMAC Mo money making this coming week.
WineauxInBordeaux
Posted - 2 months ago
@LFB1374 don’t RELY on my recommendation. Due your own DD but $DMAC is one to watch. I also like $LPTH. It won’t make you rich but it could double or triple if $LMT wins DOD contracts for nextgen stinger missile systems, to replace all those we sent to the Ukraine.
moneyshop
Posted - 2 months ago
$ABT $LLY $GILD Here is a bio Co that has break thru treatments for strokes, 2 billionaires who were former executives/founders of EQT private equity firm bought millions worth of $DMAC stock in the last capital raise. they must see a big opportunity. diamedica.com
moneyshop
Posted - 2 months ago
$AMGN Here is a bio Co that has break thru treatments for strokes, 2 billionaires who were former executives/founders of EQT private equity firm bought millions worth of $DMAC stock in the last capital raise. they must see a big opportunity. https://www.diamedica.com/
moneyshop
Posted - 2 months ago
$DMAC has a drug that saves stroke victims from brain damage if administered within 2 hours. This is a huge breakthru stock should go ballistic.
Sicksir
Posted - 2 months ago
$DMAC Break $5!
RJRNAB
Posted - 2 months ago
$DMAC volume picking up for some reason
PenkeTrading
Posted - 2 months ago
I found you an Overbought RSI (Relative Strength Index) on the daily chart of DiaMedica Therapeutics Inc. Is that bullish or bearish? $DMAC #DMAC #nasdaq #tradingsignals #technicalanalysis
Viter
Posted - 2 months ago
$DMAC As expected...
Sicksir
Posted - 2 months ago
$DMAC someone wants it
Danger_Will_Robinson
Posted - 2 months ago
$DMAC what are the odds there’s another financing …. Seems to happen every time stock makes move higher … conference presentation trail under way for this fall it looks like
Viter
Posted - 2 months ago
$DMAC soon or later we will break this wall at 4$
Sukitt
Posted - 08/29/24
$DMAC
johnbloom
Posted - 3 months ago
$DMAC still a mystery as to why 2 billionaires who were former executives/founders of EQT private equity firm would buy millions worth of $DMAC stock in the last capital raise. they must see a big opportunity with this company. very very interesting
nailman
Posted - 3 months ago
$DMAC why is the stock up? They just raised money again and there’s years of work to get anywhere with this stock. I may be wrong but it’s just seems like a pattern to me. Nothing great about the news or the company yet.
LongtermZ94
Posted - 3 months ago
Analyst thoughts on $DMAC $DMAC reported 2Q24 with EPS of ($0.13), beating both our estimate and Street consensus of ($0.16)E. On the P2/3 ReMEDy2 program, we are encouraged by the progress in site activations and high interest from sites and potential investigators, and are pleased to see 1Q25 interim enrollment timeline reiterated. However, we maintain our cautious optimism due to historical stroke trial patient enrollment challenges. On the preeclampsia program, we remind investors that we believe DM199's MOA and promising preclinical data provide a strong rationale for further clinical development. P2 still expected to initiate in 4Q24 with topline in 1H25. As DMAC continues to make strides in both its programs (only valuing AIS at this time), we reiterate our Outperform/$6 PT. $DMAC $QQQ
Tjcmd
Posted - 3 months ago
$DMAC next catalyst?
Cats_and_Roses
Posted - 3 months ago
$DMAC Nothing to see here until some time in Q1 2025, unless the next quarterly update says otherwise
Tjcmd
Posted - 3 months ago
$DMAC some clown posting this on SA